The LIMIting AAA with meTformin (LIMIT) Trial

This study will test the ability of metformin XR (extended release) to reduce the rate of enlargement of existing small- to medium-size abdominal aortic aneurysms with an effect size of 30% compared to placebo and assess the safety and tolerance of daily metformin XR therapy in non-diabetic abdominal aortic aneurysm patients.

0